Advertisement

Topics

Clearing up the mist: cardiomyocyte renewal in human hearts.

08:00 EDT 1st April 2019 | BioPortfolio

Summary of "Clearing up the mist: cardiomyocyte renewal in human hearts."

No Summary Available

Affiliation

Journal Details

This article was published in the following journal.

Name: European heart journal
ISSN: 1522-9645
Pages: 1037-1038

Links

DeepDyve research library

PubMed Articles [10349 Associated PubMed Articles listed on BioPortfolio]

Inhibition of TRPC1 prevents cardiac hypertrophy via NF-κB signaling pathway in human pluripotent stem cell-derived cardiomyocytes.

Cardiac hypertrophy is an adaptive response against increased workload featuring by an increase in left ventricular mass and a thickening left ventricle wall. Here, we showed the expression of transie...

Systemic arterial hypertension but not IGF-1 treatment stimulates cardiomyocyte enlargement in neonatal lambs.

Although cardiomyocyte terminal differentiation is nearly complete at birth in sheep, very limited postnatal expansion of myocyte number may occur. The capacity of newborn cardiomyocytes to respond to...

Endocardial Notch Signaling Promotes Cardiomyocyte Proliferation in the Regenerating Zebrafish Heart through Wnt Pathway Antagonism.

Previous studies demonstrate that the regenerative zebrafish heart responds to injury by upregulating Notch receptors in the endocardium and epicardium. Moreover, global suppression of Notch activity ...

Inhibition of cardiomyocyte Sprouty1 protects from cardiac ischemia-reperfusion injury.

Sprouty1 (Spry1) is a negative modulator of receptor tyrosine kinase signaling, but its role in cardiomyocyte survival has not been elucidated. The aim of this study was to investigate the potential r...

Absence of Cardiomyocyte Differentiation Following Transplantation of Adult Cardiac-Resident Sca-1 Cells Into Infarcted Mouse Hearts.

Clinical Trials [3039 Associated Clinical Trials listed on BioPortfolio]

Efficacy of PRF With M-MIST in the Treatment of Intrabony Defects

This study evaluates the efficacy of M-MIST with or without PRF in the treatment of intrabony defects.Taking into consideration of advantages of PRF and M-MIST it was hypothesised that thi...

Monitoring of Arrhythmias and HRV in Patients With Heart Failure Treated With the CRT Pacemaker Renewal TR2

The objective of this study is to evaluate the prevalence of sustained ventricular and supraventricular rhythm disorders in patients implanted with a CONTAK RENEWAL TR2 ventricular resynch...

Cosmetic Study of AO+Mist in Improving the Appearance of Skin Afflicted With Keratosis Pilaris

The purpose of this study is to demonstrate the safety, tolerability and efficacy of AO+ Mist administered daily for 4 weeks to improve the appearance of skin afflicted with keratosis pila...

Mesothelioma Stratified Therapy (MiST) : A Multi-drug Phase II Trial in Malignant Mesothelioma

MiST is a British Lung Foundation funded, University of Leicester Study, a multi-arm stratified therapy based clinical trial for patients with relapsed mesothelioma. The goal of MiST is t...

Seal-G MIST (Minimally Invasive Sealant/Spray Technology) System Safety Study [SEALAR Study]

The purpose of this study is to evaluate safety of Seal-G MIST System in reinforcing colorectal anastomosis, in subjects undergoing colorectal surgery.

Medical and Biotech [MESH] Definitions

Agents delivered into the nostrils in the form of a mist or spray.

Pharmacologic agents in the form of a mist or spray delivered into the body through the mouth.

The physiological renewal, repair, or replacement of tissue.

Repair or renewal of hepatic tissue.

Renewal or physiological repair of damaged nerve tissue.

Advertisement
Quick Search
Advertisement
Advertisement

 


DeepDyve research library

Searches Linking to this Article